News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
644,913 Results
Type
Article (61268)
Company Profile (69)
Press Release (583576)
Multimedia
Podcasts (59)
Webinars (13)
Section
Business (173675)
Career Advice (2729)
Deals (32423)
Drug Delivery (97)
Drug Development (76934)
Employer Resources (150)
FDA (14933)
Job Trends (13882)
News (304922)
Policy (28939)
Tag
Academia (2893)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (88)
Alliances (43145)
ALS (88)
Alzheimer's disease (1321)
Antibody-drug conjugate (ADC) (109)
Approvals (14950)
Artificial intelligence (264)
Autoimmune disease (23)
Automation (15)
Bankruptcy (290)
Best Places to Work (10855)
BIOSECURE Act (16)
Biosimilars (101)
Biotechnology (51)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (273)
Cancer (2178)
Cardiovascular disease (165)
Career advice (2312)
Career pathing (33)
CAR-T (153)
Cell therapy (427)
Cervical cancer (20)
Clinical research (62562)
Collaboration (785)
Compensation (330)
Complete response letters (20)
COVID-19 (2571)
CRISPR (43)
C-suite (260)
Cystic fibrosis (101)
Data (2149)
Decentralized trials (2)
Denatured (25)
Depression (43)
Diabetes (252)
Diagnostics (6154)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (113)
Drug pricing (97)
Drug shortages (23)
Duchenne muscular dystrophy (86)
Earnings (60110)
Editorial (38)
Employer branding (18)
Employer resources (132)
Events (94511)
Executive appointments (760)
FDA (16183)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (746)
Gene editing (109)
Generative AI (20)
Gene therapy (298)
GLP-1 (663)
Government (4456)
Grass and pollen (6)
Guidances (62)
Healthcare (18205)
Huntington's disease (19)
IgA nephropathy (25)
Immunology and inflammation (108)
Indications (28)
Infectious disease (2704)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (96)
Interviews (526)
IPO (14798)
IRA (38)
Job creations (3413)
Job search strategy (1941)
Kidney cancer (10)
Labor market (30)
Layoffs (501)
Leadership (22)
Legal (6436)
Liver cancer (69)
Lung cancer (304)
Lymphoma (145)
Machine learning (7)
Management (53)
Manufacturing (275)
MASH (63)
Medical device (12652)
Medtech (12657)
Mergers & acquisitions (18201)
Metabolic disorders (630)
Multiple sclerosis (77)
NASH (13)
Neurodegenerative disease (85)
Neuropsychiatric disorders (26)
Neuroscience (1840)
NextGen: Class of 2025 (6373)
Non-profit (4318)
Now hiring (12)
Obesity (319)
Opinion (232)
Ovarian cancer (71)
Pain (91)
Pancreatic cancer (79)
Parkinson's disease (145)
Partnered (21)
Patents (234)
Patient recruitment (110)
Peanut (50)
People (59545)
Pharmaceutical (20)
Pharmacy benefit managers (15)
Phase I (19675)
Phase II (27597)
Phase III (20179)
Pipeline (1136)
Policy (124)
Postmarket research (2473)
Preclinical (8401)
Press Release (67)
Prostate cancer (107)
Psychedelics (27)
Radiopharmaceuticals (249)
Rare diseases (362)
Real estate (5986)
Recruiting (61)
Regulatory (20096)
Reports (33)
Research institute (2396)
Resumes & cover letters (405)
Rett syndrome (5)
RNA editing (3)
RSV (35)
Schizophrenia (67)
Series A (130)
Series B (86)
Service/supplier (9)
Sickle cell disease (51)
Special edition (10)
Spinal muscular atrophy (146)
Sponsored (29)
Startups (3344)
State (1)
Stomach cancer (9)
Supply chain (54)
Tariffs (25)
The Weekly (32)
Vaccines (661)
Venture capitalists (34)
Weight loss (202)
Women's health (30)
Worklife (19)
Date
Today (153)
Last 7 days (795)
Last 30 days (2493)
Last 365 days (30588)
2025 (10094)
2024 (32292)
2023 (36354)
2022 (46650)
2021 (51605)
2020 (50740)
2019 (44780)
2018 (34065)
2017 (30727)
2016 (30084)
2015 (35487)
2014 (28401)
2013 (24971)
2012 (26251)
2011 (26482)
2010 (24961)
Location
Africa (871)
Alabama (54)
Alaska (6)
Arizona (170)
Arkansas (14)
Asia (38068)
Australia (6849)
California (5540)
Canada (1841)
China (487)
Colorado (247)
Connecticut (260)
Delaware (138)
Europe (88730)
Florida (847)
Georgia (199)
Idaho (56)
Illinois (546)
India (25)
Indiana (278)
Iowa (10)
Japan (152)
Kansas (95)
Kentucky (23)
Louisiana (10)
Maine (61)
Maryland (828)
Massachusetts (4039)
Michigan (222)
Minnesota (337)
Mississippi (2)
Missouri (87)
Montana (29)
Nebraska (23)
Nevada (57)
New Hampshire (61)
New Jersey (1637)
New Mexico (29)
New York (1625)
North Carolina (955)
North Dakota (9)
Northern California (2403)
Ohio (194)
Oklahoma (15)
Oregon (36)
Pennsylvania (1233)
Puerto Rico (12)
Rhode Island (31)
South America (1176)
South Carolina (18)
South Dakota (1)
Southern California (2117)
Tennessee (95)
Texas (846)
United States (21227)
Utah (172)
Virginia (141)
Washington D.C. (49)
Washington State (510)
West Virginia (3)
Wisconsin (59)
644,913 Results for "university of vienna".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Coya Therapeutics Selected for Platform Presentation at the ADPD 2025 Conference in Vienna on April 5, 2025
April 1, 2025
·
5 min read
BetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, Austria
BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) today announced that its scientific collaborators, Drs. Vern Lewis and Argel Aguilar-Valles from Carleton University’s Department of Neuroscience (Ottawa, Canada), will present data from a study investigating the mechanisms of BETR-001 (2-bromo-LSD) at the upcoming FENS conference on June 25-29 in Vienna, Austria.
June 26, 2024
·
4 min read
Press Releases
Alzheon to Present Results from Pivotal APOLLOE4 Phase 3 Trial of Oral Valiltramiprosate/ALZ-801 at Dedicated Symposium at ADPD Conference in Vienna on April 1st, 2025
March 18, 2025
·
10 min read
Business
MOBILion Partners with BOKU Vienna to Introduce High-Resolution Ion Mobility in Europe
MOBILion Systems, Inc., a life science tools and instrumentation company, has partnered with The University of Natural Resources and Life Sciences, Vienna, an Agilent Partner Lab, to install its first MOBIE® instrument in Europe.
January 4, 2024
·
2 min read
News
Spineway generates great interest at the EUROSPINE 2024 Congress in Vienna
October 22, 2024
·
2 min read
Press Releases
Boehringer Ingelheim expands cancer research at its Vienna site
September 26, 2024
·
3 min read
Press Releases
Alzheon Announces Two New Scientific Papers Ahead of APOLLOE4 Phase 3 Trial Topline Symposium at ADPD Conference in Vienna on April 1st, Marking 15 Pathbreaking Peer-Reviewed Publications from Alzheon
February 25, 2025
·
11 min read
Median Technologies to Participate and Speak at the 2024 European Congress of Radiology (ECR), February 28 – March 3, Vienna, Austria
Median Technologies announces that the Company will be participating and speaking at the premier European radiology conference, the European Congress of Radiology, being held in Vienna, Austria, February 28 – March 3, 2024.
February 26, 2024
·
3 min read
Biotech Beach
iTrack™ Advance Real-World Registry Data and CATALYST Study Data to be Presented at the 2023 ESCRS Annual Congress, Vienna
Nova Eye Medical Limited is pleased to announce that the Company’s proprietary canaloplasty technology platform will be featured in numerous presentations and posters during the official scientific program of the European Society of Cataract and Refractive Surgeons 41st Congress on September 8-12, 2023 in Vienna, Austria.
September 6, 2023
·
8 min read
Biotech Bay
Better Therapeutics Announces Upcoming Poster Presentation at EASL Congress 2023 in Vienna, Austria
Better Therapeutics, Inc. announced the details of its poster presentation at the European Association for the Study of the Liver Congress 2023, being held from June 21-24 in Vienna, Austria.
June 16, 2023
·
4 min read
1 of 64,492
Next
